Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin lymphoma and serves as a bridge to allogeneic stem cell transplant Meeting Abstract


Authors: Moskowitz, A. J.; Hamlin, P. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M.; Meikle, J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Vanak, J. M.; Zelenetz, A. D.; Moskowitz, C. H.
Abstract Title: Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin lymphoma and serves as a bridge to allogeneic stem cell transplant
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 300
End Page: 301
Language: English
ACCESSION: WOS:000272725800721
PROVIDER: wos
PUBMED: 22276299
DOI: 10.1182/blood.V114.22.720.720
Notes: Meeting Abstract: 720 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    206 Portlock
  2. Craig Moskowitz
    407 Moskowitz
  3. Ariela Noy
    373 Noy
  4. Maria Lia Palomba
    446 Palomba
  5. Steven M Horwitz
    668 Horwitz
  6. Andrew D Zelenetz
    784 Zelenetz
  7. Alison Moskowitz
    359 Moskowitz
  8. Paul Hamlin
    293 Hamlin
  9. Matthew J Matasar
    293 Matasar
  10. Jill M Vanak
    14 Vanak
  11. David J Straus
    361 Straus
  12. Jessica Lea Meikle
    4 Meikle